Besifloxacin liposomes with positively charged additives for an improved topical ocular delivery. 2020

Giselly Almeida Dos Santos, and Ricardo Ferreira-Nunes, and Luciana Facco Dalmolin, and Ana Carolina Dos Santos Ré, and Jorge Luiz Vieira Anjos, and Sebastião Antônio Mendanha, and Carolina Patrícia Aires, and Renata F V Lopez, and Marcilio Cunha-Filho, and Guilherme M Gelfuso, and Taís Gratieri
Laboratory of Food, Drugs, and Cosmetics (LTMAC), University of Brasilia, Brasília, DF, 70910-900, Brazil.

Topical ophthalmic antibiotics show low efficacy due to the well-known physiological defense mechanisms of the eye, which prevents the penetration of exogenous substances. Here, we aimed to incorporate besifloxacin into liposomes containing amines as positively charged additives and to evaluate the influence of this charge on drug delivery in two situations: (i) iontophoretic and (ii) passive treatments. Hypothesis are (i) charge might enhance the electromigration component upon current application improving penetration efficiency for a burst drug delivery, and (ii) positive charge might prolong formulation residence time, hence drug penetration. Liposomes elaborated with phosphatidylcholine (LP PC) or phosphatidylcholine and spermine (LP PC: SPM) were stable under storage at 6 ºC for 30 days, showed mucoadhesive characteristics, and were non-irritant, according to HET-CAM tests. Electron paramagnetic resonance spectroscopy measurements showed that neither the drug nor spermine incorporations produced evident alterations in the fluidity of the liposome's membranes, which retained their structural stability even under iontophoretic conditions. Mean diameter and zeta potential were 177.2 ± 2.7 nm and - 5.7 ± 0.3 mV, respectively, for LP PC; and 175.4 ± 1.9 nm and + 19.5 ± 1.0 mV, respectively, for LP PC:SPM. The minimal inhibitory concentration (MIC) and the minimal bactericide concentration (MBC) of the liposomes for P. aeruginosa showed values lower than the commercial formulation (Besivance). Nevertheless, both formulations presented a similar increase in permeability upon the electric current application. Hence, liposome charge incorporation did not prove to be additionally advantageous for iontophoretic therapy. Passive drug penetration was evaluated through a novel in vitro ocular model that simulates the lacrimal flow and challenges the formulation resistance in the passive delivery situation. As expected, LP PC: SPM showed higher permeation than the control (Besivance). In conclusion, besifloxacin incorporation into positively charged liposomes improved passive topical delivery and can be a good strategy to improve topical ophthalmic treatments.

UI MeSH Term Description Entries
D008081 Liposomes Artificial, single or multilaminar vesicles (made from lecithins or other lipids) that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and membrane proteins. Niosomes,Transferosomes,Ultradeformable Liposomes,Liposomes, Ultra-deformable,Liposome,Liposome, Ultra-deformable,Liposome, Ultradeformable,Liposomes, Ultra deformable,Liposomes, Ultradeformable,Niosome,Transferosome,Ultra-deformable Liposome,Ultra-deformable Liposomes,Ultradeformable Liposome
D010539 Permeability Property of membranes and other structures to permit passage of light, heat, gases, liquids, metabolites, and mineral ions. Permeabilities
D010713 Phosphatidylcholines Derivatives of PHOSPHATIDIC ACIDS in which the phosphoric acid is bound in ester linkage to a CHOLINE moiety. Choline Phosphoglycerides,Choline Glycerophospholipids,Phosphatidyl Choline,Phosphatidyl Cholines,Phosphatidylcholine,Choline, Phosphatidyl,Cholines, Phosphatidyl,Glycerophospholipids, Choline,Phosphoglycerides, Choline
D005123 Eye The organ of sight constituting a pair of globular organs made up of a three-layered roughly spherical structure specialized for receiving and responding to light. Eyes
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001381 Azepines Seven membered heterocyclic rings containing a NITROGEN atom. Hexamethyleneimines
D013552 Swine Any of various animals that constitute the family Suidae and comprise stout-bodied, short-legged omnivorous mammals with thick skin, usually covered with coarse bristles, a rather long mobile snout, and small tail. Included are the genera Babyrousa, Phacochoerus (wart hogs), and Sus, the latter containing the domestic pig (see SUS SCROFA). Phacochoerus,Pigs,Suidae,Warthogs,Wart Hogs,Hog, Wart,Hogs, Wart,Wart Hog
D060433 Administration, Ophthalmic Application of pharmaceutically active agents on the tissues of the EYE. Ocular Administration,Administration, Ocular,Administrations, Ocular,Administrations, Ophthalmic,Ocular Administrations,Ophthalmic Administration,Ophthalmic Administrations
D024841 Fluoroquinolones A group of QUINOLONES with at least one fluorine atom and a piperazinyl group. Fluoroquinolone

Related Publications

Giselly Almeida Dos Santos, and Ricardo Ferreira-Nunes, and Luciana Facco Dalmolin, and Ana Carolina Dos Santos Ré, and Jorge Luiz Vieira Anjos, and Sebastião Antônio Mendanha, and Carolina Patrícia Aires, and Renata F V Lopez, and Marcilio Cunha-Filho, and Guilherme M Gelfuso, and Taís Gratieri
January 2003, Cellular & molecular biology letters,
Giselly Almeida Dos Santos, and Ricardo Ferreira-Nunes, and Luciana Facco Dalmolin, and Ana Carolina Dos Santos Ré, and Jorge Luiz Vieira Anjos, and Sebastião Antônio Mendanha, and Carolina Patrícia Aires, and Renata F V Lopez, and Marcilio Cunha-Filho, and Guilherme M Gelfuso, and Taís Gratieri
January 2008, International journal of pharmaceutics,
Giselly Almeida Dos Santos, and Ricardo Ferreira-Nunes, and Luciana Facco Dalmolin, and Ana Carolina Dos Santos Ré, and Jorge Luiz Vieira Anjos, and Sebastião Antônio Mendanha, and Carolina Patrícia Aires, and Renata F V Lopez, and Marcilio Cunha-Filho, and Guilherme M Gelfuso, and Taís Gratieri
May 1986, Cell biology international reports,
Giselly Almeida Dos Santos, and Ricardo Ferreira-Nunes, and Luciana Facco Dalmolin, and Ana Carolina Dos Santos Ré, and Jorge Luiz Vieira Anjos, and Sebastião Antônio Mendanha, and Carolina Patrícia Aires, and Renata F V Lopez, and Marcilio Cunha-Filho, and Guilherme M Gelfuso, and Taís Gratieri
January 2006, Biomaterials,
Giselly Almeida Dos Santos, and Ricardo Ferreira-Nunes, and Luciana Facco Dalmolin, and Ana Carolina Dos Santos Ré, and Jorge Luiz Vieira Anjos, and Sebastião Antônio Mendanha, and Carolina Patrícia Aires, and Renata F V Lopez, and Marcilio Cunha-Filho, and Guilherme M Gelfuso, and Taís Gratieri
March 1999, Journal of controlled release : official journal of the Controlled Release Society,
Giselly Almeida Dos Santos, and Ricardo Ferreira-Nunes, and Luciana Facco Dalmolin, and Ana Carolina Dos Santos Ré, and Jorge Luiz Vieira Anjos, and Sebastião Antônio Mendanha, and Carolina Patrícia Aires, and Renata F V Lopez, and Marcilio Cunha-Filho, and Guilherme M Gelfuso, and Taís Gratieri
May 1999, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Giselly Almeida Dos Santos, and Ricardo Ferreira-Nunes, and Luciana Facco Dalmolin, and Ana Carolina Dos Santos Ré, and Jorge Luiz Vieira Anjos, and Sebastião Antônio Mendanha, and Carolina Patrícia Aires, and Renata F V Lopez, and Marcilio Cunha-Filho, and Guilherme M Gelfuso, and Taís Gratieri
April 1988, The Journal of cell biology,
Giselly Almeida Dos Santos, and Ricardo Ferreira-Nunes, and Luciana Facco Dalmolin, and Ana Carolina Dos Santos Ré, and Jorge Luiz Vieira Anjos, and Sebastião Antônio Mendanha, and Carolina Patrícia Aires, and Renata F V Lopez, and Marcilio Cunha-Filho, and Guilherme M Gelfuso, and Taís Gratieri
June 2010, Drug development and industrial pharmacy,
Giselly Almeida Dos Santos, and Ricardo Ferreira-Nunes, and Luciana Facco Dalmolin, and Ana Carolina Dos Santos Ré, and Jorge Luiz Vieira Anjos, and Sebastião Antônio Mendanha, and Carolina Patrícia Aires, and Renata F V Lopez, and Marcilio Cunha-Filho, and Guilherme M Gelfuso, and Taís Gratieri
July 2021, Expert opinion on drug delivery,
Giselly Almeida Dos Santos, and Ricardo Ferreira-Nunes, and Luciana Facco Dalmolin, and Ana Carolina Dos Santos Ré, and Jorge Luiz Vieira Anjos, and Sebastião Antônio Mendanha, and Carolina Patrícia Aires, and Renata F V Lopez, and Marcilio Cunha-Filho, and Guilherme M Gelfuso, and Taís Gratieri
January 1999, Journal of drug targeting,
Copied contents to your clipboard!